INOVIQ has developed and commercialised EXO-NET to enable fast, efficient and scalable exosome isolation from biofluids to intercept and decode the messages they contain. This information can be used for assessing patient well-being or disease risk, diagnosis of disease, selecting the best treatment option, or monitoring a patient’s response to treatment. The global exosome research market was valued at US$144 million in 2021 and is expected to reach US$661 million by 2026, growing at a CAGR of 35.6%5. North America was the largest geographic segment representing 41.5% of the market followed by Europe at 20%. The Kits and Reagents product segment in which INOVIQ’s EXO-NET research tools fit, was valued at US$71 million in 2021 and is forecast to reach US$311 million by 2026. The global exosomes market for research, diagnostics and therapeutics was valued at US$1.8 billion in 2022 and is forecast to reach US$8.7 billion by 2029, growing at 25% CAGR6. Market growth is driven by increased investment in exosome research, the rising prevalence of chronic diseases, increased demand for non-invasive diagnostics and targeted therapies, and technological advancements in exosome isolation and purification. Review of Operations 5 2022. Exosome Research Market - Global Forecast to 2026. Markets&Markets 6 2023. Exosomes Market: Global Industry Analysis and Forecast for the Period 2023-2029. MMR: www.maximizemarketresearch.com/ market-report/exosomes-market/189733/ Extracellular Vesicle (EV) 10 INOVIQ Limited
RkJQdWJsaXNoZXIy MjE2NDg3